Rhythm Pharmaceuticals, Inc. (RYTM)
After hours:
| Previous Close | 39.01 |
| Open | 39.39 |
| Bid | 39.85 x 200 |
| Ask | 39.98 x 100 |
| Day's Range | 39.19 - 41.79 |
| 52 Week Range | 15.50 - 52.57 |
| Volume | |
| Avg. Volume | 585,782 |
| Market Cap | 2.406B |
| Beta (5Y Monthly) | 1.93 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.20 |
| Earnings Date | Apr 30, 2024 - May 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 58.78 |
GlobeNewswireRhythm Pharmaceuticals Announces New Employment Inducement Grants
BOSTON, April 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that on April 11, 2024, the Compensation Committee of Rhythm’s board of directors granted inducement equity grants covering an aggregate of 31,220 shares of its common stock to eight new employees, consisting of inducement stock options to purc
Simply Wall St.Market Sentiment Around Loss-Making Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
Rhythm Pharmaceuticals, Inc. ( NASDAQ:RYTM ) is possibly approaching a major achievement in its business, so we would...
ZacksModerna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?
Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
